Emergency Medicine and Addiction Medicine: Research and Career Development Opportunities (Toxicology Interest Group-Sponsored)

Emergency medicine and addiction medicine offer unique opportunities for research and career development, supported by federal funding. Addiction medicine, a one-year fellowship after emergency medicine residency, focuses on treating vulnerable populations. Dually trained clinicians are emerging as leaders with access to federal, foundation, and industry funding to advance addiction science and improve substance use outcomes. This panel, featuring emergency medicine/addiction medicine researchers and a National Institute on Drug Abuse program officer, will highlight training opportunities, funding strategies, and mentorship programs for residents. By fostering collaboration, we can improve care and address the national substance use disorder crisis.

Learning Objectives:

Upon completion of this session, participants should be able to:
  • Describe research training and a career trajectory focused on emergency medicine and addiction medicine.
  • Discuss the landscape of funded training opportunities including NIDA K12, Neuro-EM K12, T32 programs as well as individual K awards.
  • Identify strategies for a successful career as a physician scientist.

Presenters:

  • Kathryn Hawk, MD, MHS
  • Andrew A. Herring, MD
  • Jeanmarie Perrone, MD
  • Gail D'Onofrio, MD, MS
Authors

  • Kathryn Hawk, MD, MHS

    Yale School of Medicine

    Kathryn Hawk, MD, MHS is an attending physician in the Yale New Haven Hospital Emergency Department and an Associate Professor in the Department of Emergency Medicine, the Yale School of Public Health and the Program in Addiction Medicine. She was a National Institute on Drug Abuse (NIDA) K12 sponsored Drug use, Addiction and HIV Research (DAHRS) Scholar, and is board certified in emergency and addiction medicine. She completed her residency training and research fellowship in the Yale University Department of Emergency Medicine. Her research primarily focuses on the design, testing and implementation of evidence based-care for ED patients with substance use disorders, with an emphasis on initiating medications for opioid and alcohol use disorder in the ED and maximizing effective linkage to ongoing treatment using innovative strategies. Her research on quality improvement and reducing opioid-associated mortality through data linkages, implementation-facilitation ED-initiated buprenorphine for opioid use disorder, initiating treatment for alcohol use disorder in the ED and the dissemination of evidence-based best practices for care of patients with addiction has been funded by NIDA, the Centers for Disease Control and Prevention (CDC), Emergency Medicine Foundation (EMF), Foundation for Opioid Response (FORE), and the National Institute on Alcohol Abuse and Alcoholism (NIAAA).


  • Andrew A. Herring, MD

    Highland Hospital - Alameda Health System

    Dr. Andrew A Herring graduated Bowdoin College and graduated from Harvard Medical School then completed residency in emergency medicine at Highland General Hospital—Alameda Health System in Oakland, CA where he is Chief of Addiction Medicine overseeing inpatient addiction services, emergency department based services, an outpatient addiction medicine clinic and a regional substance use disorder telemedicine hotline. Dr. Herring is board certified in Pain Medicine and the past Medical Director of the Alameda Health System Functional Restoration Pain Clinic. Dr Herring has led national efforts to transform hospital-based care for substance use disorders and his work has been featured in local and national press including the New York Times, Los Angeles Times and National Public Radio. Dr. Herring co-founded CA BRIDGE and the Bridge Center at the Public Health Institute. Dr. Herring’s research has been funded by the National Institutes of Health (NIH) and the Patient-Centered Outcomes Research Institute (PCORI) and has been published in numerous journals including JAMA Open and Annals of Emergency Medicine. Dr. Herring leads several NIDA supported clinical trials and is principal investigator for the Public Health Institute CA Bridge Outcomes Study. He was a Fulbright Scholar in Central America focused on supporting migrant health and co-founded the Street Level Health Project in Oakland, California that is dedicated to supporting undocumented day laborers. Dr. Herring is board-certified in Emergency Medicine, and Addiction Medicine, and Pain Medicine and is an Assistant Clinical Professor at the University of California, San Francisco.

  • Jeanmarie Perrone, MD

    University of Pennsylvania

    Jeanmarie Perrone, MD is a Professor in the Department of Emergency Medicine and the founding Director of the Penn Center for Addiction Medicine and Policy at the University of Pennsylvania. Dr. Perrone leads a program for the treatment of Opioid Use Disorder in the emergency department (ED) and a virtual telehealth bridge clinic (CareConnect) for low barrier access to medications for opioid use disorder. She has advocated at the state and national level for enhancing equitable care for substance use. She has attended numerous FDA meetings while serving on the Drug Safety and Risk Management Advisory Committee and is a lead Co-Investigator on a NIDA CTN multi-site study of ED initiated buprenorphine. She has won numerous awards for education and mentorship and is board certified in emergency medicine, medical toxicology and addiction medicine.

  • Gail D'Onofrio, MD, MS

    Albert E. Kent Professor of Emergency Medicine

    Yale University

    Gail D’Onofrio, MD, MS is the Albert E. Kent Professor of Emergency Medicine and Professor of Medicine and Public Health at Yale University Schools of Medicine and Public Health. She has extensive experience as a leader, researcher, mentor, and educator, internationally known for her work in substance use disorders. As a physician-scientist she has had continual NIH-funding for over two decades, designing and conducting clinical trials that have changed clinical practice. In addition, she was one of the founding members of the Board of Addiction Medicine, that became recognized as a ABMS approved subspecialty in 2016, sponsored by the American Board of Preventive Medicine. Dr. D’Onofrio is the MPI of the New England Consortium Node for the NIDA Clinical Trials Network and is the MPI of both a NIDA-funded and NINDS funded K12 training program. She is committed to preparing young faculty to become independent investigators advancing the science of Emergency and Addiction Medicine. 

Related Media